Successful treatment of a congenital extra-truncal vascular malformation by orally administered propranolol
- 20 December 2013
- journal article
- case report
- Published by Informa UK Limited in Journal of Dermatological Treatment
- Vol. 26 (1), 59-62
- https://doi.org/10.3109/09546634.2013.869301
Abstract
The β-blocker propranolol has become a valuable and effective drug for the treatment of infantile hemangiomas. Its therapeutic action probably results from vasoconstriction, blocking of angiogenesis through effects on vascular endothelial growth factor and induction of apoptosis. It is reasonable to suggest that propranolol can also be used effectively in the treatment of other vascular abnormalities. This case report describes propranolol treatment of vascular malformations such as Klippel–Trénaunay syndrome or Parkes–Weber syndrome in adults.Keywords
This publication has 18 references indexed in Scilit:
- Hämangiome. Neue Aspekte zu Pathogenese, Differenzialdiagnosen und TherapieDie Dermatologie, 2012
- Propranolol as antiangiogenic candidate for the therapy of hereditary haemorrhagic telangiectasiaThrombosis and Haemostasis, 2012
- Diagnosis and management of extensive vascular malformations of the lower limb: Part II. Systemic repercussions, diagnosis, and treatmentJournal of the American Academy of Dermatology, 2011
- Diagnosis and management of extensive vascular malformations of the lower limb: Part I. Clinical diagnosisJournal of the American Academy of Dermatology, 2011
- Propranolol for Severe Hemangiomas of InfancyNew England Journal of Medicine, 2008
- Identification of an angiogenic factor that when mutated causes susceptibility to Klippel–Trenaunay syndromeNature, 2004
- Capillary Malformation–Arteriovenous Malformation, a New Clinical and Genetic Disorder Caused by RASA1 MutationsAmerican Journal of Human Genetics, 2003
- BETA BLOCKADE INDUCES APOPTOSIS IN CULTURED CAPILLARY ENDOTHELIAL CELLSIn Vitro Cellular & Developmental Biology – Animal, 2002
- cAMP-dependent protein kinase inhibits the mitogenic action of vascular endothelial growth factor and fibroblast growth factor in capillary endothelial cells by blocking Raf activationJournal of Cellular Biochemistry, 1997
- Klippel-Trenaunay syndrome: Clinical features, complications and management in childrenBritish Journal of Surgery, 1995